Predicting sentinel node positivity in patients with melanoma: external validation of a risk-prediction calculator (the Melanoma Institute Australia nomogram) using a large European population-based patient cohort.
Mary-Ann El SharouniAlexander H R VareyA J WitkampT AhmedV SigurdssonP J van DiestRichard A ScolyerJohn F ThompsonSerigne N LôCarla Henrica van GilsPublished in: The British journal of dermatology (2021)
This population-based validation study in European patients with melanoma confirmed the value of the MIA nomogram in predicting SN positivity. Its use will spare low-risk patients the inconvenience, cost and potential risks of SN biopsy while ensuring that high-risk patients are still identified.